Kate Hermans

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Kate Hermans
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kate Hermans:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. Director Ordinary Shares 85,000 $785,800 $9.24 07 Jun 2023 Direct
Ambrx Biopharma, Inc. Director Restricted Stock Units 0 $0 $9.82 07 Mar 2024 Direct
Ambrx Biopharma, Inc. Director Option to Purchase Common Stock 0 07 Mar 2024 Direct

Insider Reports Filed by Kate Hermans

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024028250-hermans-kate-2024-03-07 Ambrx Biopharma, Inc. 07 Mar 2024 4 $0 4 Director 07 Mar 2024, 19:23
/report/000089924323015148-hermans-kate-2023-06-07 Ambrx Biopharma Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:05
/report/000120919123005788-hermans-kate-2023-01-27 Ambrx Biopharma Inc. 27 Jan 2023 6 $0 4 Director 31 Jan 2023, 17:07
/report/000120919123000391-hermans-kate-2023-01-01 Ambrx Biopharma Inc. 01 Jan 2023 0 $0 3 Director 03 Jan 2023, 17:06